Related Experiment Video
Updated: Aug 2, 2026

Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
Published on: June 8, 2012
Enhanced Macrophage Uptake of Spray-Dried Phosphatidylserine-Loaded Microparticles for Pulmonary Drug Delivery
Matthew T Freeman1, Arianne Parvaresh-Rizi2, Samantha A Meenach1,3
1Department of Chemical Engineering, University of Rhode Island, Kingston, RI 02881 USA.
Abstract:
Macrophages are an integral part of the innate immune system and act as a first line of defense to pathogens; however, macrophages can be reservoirs for pathogens to hide and replicate. Tuberculosis, influenza virus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are common diseases whose pathogens are uptaken into macrophages. Current treatments for diseases such as these are limited by the therapeutic delivery method, which typically involves systemic delivery in large, frequent doses. This study aims to overcome this limitation via the development of an inhalable dry powder microparticle (MP) formulation capable of targeted drug delivery to alveolar macrophages in addition to controlled release of a therapeutic. A simple one-step spray drying method was used to synthesize acetalated dextran (Ac-Dex) MP loaded with the model therapeutic, curcumin, and 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (DPPS), which is a phospholipid that induces ligand-receptor mediated macrophage phagocytosis. The resulting MP exhibited significantly more uptake by RAW 264.7 macrophages in comparison to MP without DPPS, and it was shown that DPPS-mediated uptake was macrophage specific. The particles exhibited pH-responsive release and in vitro aerosol dispersion analysis confirmed the MP can be effectively aerosolized for pulmonary delivery. Overall, the described MP has the potential to improve treatment efficacy for macrophage-associated diseases.
Insights
This study developed inhalable microparticles (MPs) for targeted drug delivery to alveolar macrophages. The MPs enhance drug uptake by macrophages, improving treatments for macrophage-associated diseases.
Area of Science:
- Immunology
- Nanotechnology
- Drug Delivery
Background:
- Macrophages are crucial for innate immunity but can harbor pathogens like SARS-CoV-2.
- Current treatments for macrophage-associated diseases often require systemic delivery, leading to inefficiencies.
- Targeted drug delivery to macrophages offers a promising therapeutic strategy.
Purpose of the Study:
- To develop an inhalable dry powder microparticle (MP) formulation for targeted drug delivery to alveolar macrophages.
- To achieve controlled release of therapeutics within macrophages.
- To overcome limitations of conventional systemic drug delivery methods.
Main Methods:
- Synthesized acetalated dextran (Ac-Dex) MPs using a one-step spray drying method.
- Loaded MPs with curcumin (model therapeutic) and 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (DPPS) to enhance macrophage uptake.
- Evaluated MP uptake by RAW 264.7 macrophages and assessed pH-responsive drug release and aerosolization properties.
Main Results:
- DPPS-loaded MPs showed significantly enhanced and macrophage-specific uptake compared to control MPs.
- The microparticles demonstrated pH-responsive drug release.
- In vitro aerosol dispersion analysis confirmed the potential for effective pulmonary delivery.
Conclusions:
- The developed inhalable MPs demonstrate potential for targeted delivery and controlled release of therapeutics to alveolar macrophages.
- DPPS-mediated uptake enhances therapeutic efficacy for macrophage-associated diseases.
- This formulation offers a promising approach to improve treatment outcomes for pulmonary infections and inflammatory conditions.
More Related Videos
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
09:34Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
Published on: February 9, 2019
Related Concept Videos
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Inhaled Medications
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Bioavailability Enhancement: Drug Permeability Enhancement